Literature DB >> 20503405

Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge.

Peter B Vermeulen1, Kenneth L van Golen, Luc Y Dirix.   

Abstract

This objective of the current review was to provide the reader with a comprehensive summary of the literature related to 3 important and inter-related features of the biology of inflammatory breast cancer (IBC): angiogenesis, lymphangiogenesis, and the formation of tumor emboli. Information derived from animal models of IBC as well as from translational studies using tissue samples of patients with IBC are discussed. Copyright 2010 American Cancer Society.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20503405     DOI： 10.1002/cncr.25169

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  39 in total

Review 1.  Multiscale imaging and computational modeling of blood flow in the tumor vasculature.

Authors:  Eugene Kim; Spyros Stamatelos; Jana Cebulla; Zaver M Bhujwalla; Aleksander S Popel; Arvind P Pathak
Journal:  Ann Biomed Eng       Date:  2012-05-08       Impact factor: 3.934

2.  An unexpected diagnosis of breast malignancy.

Authors:  T Richardson; F Cottier
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

3.  How do I treat inflammatory breast cancer?

Authors:  Della Makower; Joseph A Sparano
Journal:  Curr Treat Options Oncol       Date:  2013-03

Review 4.  Molecular background of the regional lymph node metastasis of gastric cancer.

Authors:  Tong Zhu; Xueqian Hu; Pinkang Wei; Guangzhi Shan
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

Review 5.  Three-dimensional culture systems in cancer research: Focus on tumor spheroid model.

Authors:  Sritama Nath; Gayathri R Devi
Journal:  Pharmacol Ther       Date:  2016-04-08       Impact factor: 12.310

6.  Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.

Authors:  Komal Jhaveri; Eleonora Teplinsky; Deborah Silvera; Amanda Valeta-Magara; Rezina Arju; Shah Giashuddin; Yasmeen Sarfraz; Melissa Alexander; Farbod Darvishian; Paul H Levine; Salman Hashmi; Ladan Zolfaghari; Heather J Hoffman; Baljit Singh; Judith D Goldberg; Tsivia Hochman; Silvia Formenti; Francisco J Esteva; Meena S Moran; Robert J Schneider
Journal:  Clin Breast Cancer       Date:  2015-12-01       Impact factor: 3.225

7.  Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study.

Authors:  Catherine Schairer; Cecile A Laurent; Lisa M Moy; Gretchen L Gierach; Neil E Caporaso; Ruth M Pfeiffer; Lawrence H Kushi
Journal:  Breast Cancer Res Treat       Date:  2020-07-20       Impact factor: 4.872

8.  Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA.

Authors:  Ke Xiao; Zhengxiao Ouyang; Hui-Huan Tang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

9.  ¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.

Authors:  Laurence Champion; Florence Lerebours; Pascal Cherel; Veronique Edeline; Anne-Laure Giraudet; Myriam Wartski; Dominique Bellet; Jean-Louis Alberini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-03       Impact factor: 9.236

10.  Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression.

Authors:  Yangyang Ge; Jia Liu; Xi Yang; Hongcheng Zhu; Baixia Yang; Kuiling Zhao; Zhijun Wu; Guojian Cheng; Feng Wang; Feng Ni; Qin Ge; Yanguang Yang; Guomei Tai; Xinchen Sun; Jing Cai
Journal:  Tumour Biol       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.